Skip to content

PHARMACIE DU SQUARE: what changed

What changed

PHARMACIE DU SQUARE

BE 0449.859.175
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€148,582
2024 · €200,676-€52,094
Equity
€1.1m
2024 · €961,055+€148,582
Cash
€357,719
2024 · €254,292+€103,427
Balance sheet total
€1.3m
2024 · €1.2m+€87,883

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€579,361

    up €579,361 (+603%), from €96,016 to €675,377

    of which Other amounts receivable: +€548,869

  • Financial fixed assets -€564,310

    no longer reported in 2025 (was €564,310)

  • Cash +€103,427

    up €103,427 (+40.7%), from €254,292 to €357,719

    mainly Investment in fixed assets (net) (+€564,310) and Net result for the year (+€148,582)

  • Tangible fixed assets -€20,736

    down €20,736 (-16.0%), from €129,912 to €109,177

    of which Plant, machinery and equipment: -€12,527

Equity and liabilities
  • Profit (loss) carried forward +€633,582

    up €633,582 (+939%), from €67,455 to €701,037

  • Reserves -€485,000

    down €485,000 (-55.4%), from €875,000 to €390,000

    of which Distributable reserves: -€465,000

  • Other debts -€73,605

    down €73,605 (-92.0%), from €80,000 to €6,395

  • Trade debts +€16,852

    up €16,852 (+14.5%), from €116,613 to €133,466

Income statement
  • Financial income -€61,700

    down €61,700 (-93.7%), from €65,846 to €4,145

  • Taxes -€47,829

    down €47,829 (-50.8%), from €94,109 to €46,280

  • Write-downs +€31,219

    new in 2025: €31,219

  • Staff costs +€12,420

    up €12,420 (+11.4%), from €108,910 to €121,330

  • Gross operating margin +€5,245

    up €5,245 (+1.5%), from €359,490 to €364,736

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €200,676
Gross operating margin +€5,245
Staff costs -€12,420
Depreciation +€140
Write-downs -€31,219
Other operating charges -€48
Financial income -€61,700
Financial charges +€79
Taxes +€47,829
Result 2025 €148,582
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€460,883
Investment +€564,310
Financing €0
Cash 2024 €254,292
Net result for the year +€148,582
Depreciation +€20,736
Stocks and contracts +€8,932
Receivables within one year -€579,361
Deferred charges and accrued income +€928
Trade debts +€16,852
Tax, wage and social debts -€3,947
Other debts -€73,605
Investment in fixed assets (net) +€564,310
Cash 2025 €357,719
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,220,485 €1,308,368 +€87,883 +7.2%
Fixed assets 21/28 €694,223 €109,177 -€585,046 -84.3%
Tangible fixed assets 22/27 €129,912 €109,177 -€20,736 -16.0%
Land and buildings 22 €23,061 €17,494 -€5,567 -24.1%
Plant, machinery and equipment 23 €71,486 €58,959 -€12,527 -17.5%
Furniture and vehicles 24 €35,365 €32,724 -€2,642 -7.5%
Financial fixed assets 28 €564,310 - -€564,310
Current assets 29/58 €526,262 €1,199,191 +€672,929 +128%
Stocks and contracts in progress 3 €168,776 €159,844 -€8,932 -5.3%
Stocks 30/36 €168,776 €159,844 -€8,932 -5.3%
Amounts receivable within one year 40/41 €96,016 €675,377 +€579,361 +603%
Trade receivables 40 €80,571 €111,063 +€30,492 +37.8%
Other amounts receivable 41 €15,445 €564,314 +€548,869 +3,554%
Cash at bank and in hand 54/58 €254,292 €357,719 +€103,427 +40.7%
Deferred charges and accrued income 490/1 €7,178 €6,250 -€928 -12.9%
Total equity and liabilities 10/49 €1,220,485 €1,308,368 +€87,883 +7.2%
Equity 10/15 €961,055 €1,109,637 +€148,582 +15.5%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €875,000 €390,000 -€485,000 -55.4%
Non-distributable reserves 130/1 €20,000 - -€20,000
Reserves not available under the articles 1311 €20,000 - -€20,000
Distributable reserves 133 €855,000 €390,000 -€465,000 -54.4%
Profit (loss) carried forward 14 €67,455 €701,037 +€633,582 +939%
Amounts payable 17/49 €259,430 €198,730 -€60,700 -23.4%
Amounts payable within one year 42/48 €259,430 €198,730 -€60,700 -23.4%
Trade debts 44 €116,613 €133,466 +€16,852 +14.5%
Suppliers 440/4 €116,613 €133,466 +€16,852 +14.5%
Taxes, remuneration and social security 45 €62,817 €58,870 -€3,947 -6.3%
Taxes 450/3 €46,457 €43,428 -€3,028 -6.5%
Remuneration and social security 454/9 €16,360 €15,442 -€918 -5.6%
Other amounts payable 47/48 €80,000 €6,395 -€73,605 -92.0%
Remuneration, social security and pensions 62 €108,910 €121,330 +€12,420 +11.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €20,875 €20,736 -€140 -0.7%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €31,219 +€31,219
Other operating charges 640/8 €1 €49 +€48 +7,769%
Gross operating margin 9900 €359,490 €364,736 +€5,245 +1.5%
Operating profit (loss) 9901 €229,705 €191,403 -€38,302 -16.7%
Financial income 75/76B €65,846 €4,145 -€61,700 -93.7%
Recurring financial income 75 €65,846 €4,145 -€61,700 -93.7%
Financial charges 65/66B €766 €687 -€79 -10.3%
Recurring financial charges 65 €766 €687 -€79 -10.3%
Profit (loss) for the period before taxes 9903 €294,785 €194,862 -€99,923 -33.9%
Income taxes 67/77 €94,109 €46,280 -€47,829 -50.8%
Profit (loss) for the period 9904 €200,676 €148,582 -€52,094 -26.0%
Profit (loss) for the period to be appropriated 9905 €200,676 €148,582 -€52,094 -26.0%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.